BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10997139)

  • 1. Cross-reactivity between Coxiella burnetii and chlamydiae.
    Lukácová M; Melnicáková J; Kazár J
    Folia Microbiol (Praha); 1999; 44(5):579-84. PubMed ID: 10997139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological consequences of Coxiella burnetii phase variation.
    Quevedo Diaz MA; Lukácová M
    Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray.
    Beare PA; Chen C; Bouman T; Pablo J; Unal B; Cockrell DC; Brown WC; Barbian KD; Porcella SF; Samuel JE; Felgner PL; Heinzen RA
    Clin Vaccine Immunol; 2008 Dec; 15(12):1771-9. PubMed ID: 18845831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations concerning the prevalence of Coxiella burnetii and Chlamydia abortus in sheep in correlation with management systems and abortion rate in Lower Saxony in 2004.
    Runge M; Binder A; Schotte U; Ganter M
    Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):138-43. PubMed ID: 22515032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the sensitivity of selected serological tests and activity of Coxiella burnetii antigens in the diagnosis of Q fever].
    Tylewska-Wierzbanowska S; Kruszewska D
    Med Dosw Mikrobiol; 1991; 43(3-4):119-26. PubMed ID: 1823374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and antigenic characterization of Coxiella burnetii strains isolated in Europe and Mongolia.
    Kovácová E; Vavreková M; Lukácová M; Daiter AB; Tokarevich NK; Karceva NA; Gorbachev EN; Urvolgyi J; Kocianová E; Rehácek J
    Eur J Epidemiol; 1994 Feb; 10(1):9-15. PubMed ID: 7957797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.
    Kazár J; Gajdosová E; Kovácová E; Valková D
    Acta Virol; 1995 Dec; 39(5-6):243-9. PubMed ID: 8722292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblot analysis of IgG subclass antibody response against Coxiella burnetii in Balb/c mice.
    Thiele D; Willems H; Glas M
    Acta Virol; 1992 Jan; 36(1):73-8. PubMed ID: 1350177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X; Xiong X; Graves S; Stenos J; Wen B
    Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.
    Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE
    Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to Coxiella burnetii that cross-react with strain Nine Mile.
    Sekeyová Z; Kovácová E; Kazár J; Toman R; Olvecká S
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):531-4. PubMed ID: 8548530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of Coxiella burnetii (Q fever) immunoglobulin M.
    Field PR; Mitchell JL; Santiago A; Dickeson DJ; Chan SW; Ho DW; Murphy AM; Cuzzubbo AJ; Devine PL
    J Clin Microbiol; 2000 Apr; 38(4):1645-7. PubMed ID: 10747159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies are generated during infection to Coxiella burnetii macrophage infectivity potentiator protein (Cb-Mip).
    Seshu J; McIvor KL; Mallavia LP
    Microbiol Immunol; 1997; 41(4):371-6. PubMed ID: 9159413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of cattle and livestock handlers with Coxiella burnetti and Chlamydiae in the farm of Bernolákovo (West Slovakia).
    Sádecký E
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):52-9. PubMed ID: 7229356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low antibodies titer and serological cross-reaction between Coxiella burnetii and Legionella pneumophila challenge the diagnosis of mediastinitis, an emerging Q fever clinical entity.
    Edouard S; Million M; Casalta JP; Collart F; Amphoux B; Raoult D
    Infection; 2017 Dec; 45(6):911-915. PubMed ID: 28779434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a recombinant 27-kDa outer membrane protein of Coxiella burnetii as an immunodiagnostic reagent.
    Zhang GQ; Hotta A; Ho T; Yamaguchi T; Fukushi H; Hirai K
    Microbiol Immunol; 1998; 42(6):423-8. PubMed ID: 9688076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three serological tests for the detection of Coxiella burnetii specific antibodies in European wild rabbits.
    Caraguel C; Bassett S; González-Barrio D; Elsworth P; Chaber AL
    BMC Vet Res; 2020 Aug; 16(1):315. PubMed ID: 32859195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.
    Zhang GQ; Samuel JE
    Ann N Y Acad Sci; 2003 Jun; 990():510-20. PubMed ID: 12860683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to Coxiella burnetii for antigenic detection in cell cultures and in paraffin-embedded tissues.
    Raoult D; Laurent JC; Mutillod M
    Am J Clin Pathol; 1994 Mar; 101(3):318-20. PubMed ID: 8135188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblot analysis of antibody response in mice infected with Coxiella burnetii phase I.
    Novák M; Brezina R; Kazár J
    Acta Virol; 1992 Jan; 36(1):39-44. PubMed ID: 1350170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.